Patients Will Soon Have a Device to Control Their BP
Submitted by Neeraj Shahane on Wed, 04/06/2011 - 10:51
Scientists have developed a device called Rheos System, to control the blood pressure of patients with resistant hypertension. In clinical trials, the device has helped lowering the blood pressure of the patients by 33%. The trials were conducted on 265 patients with resistant hypertension treated at 40 medical centers in the United States and two in Europe.
The Rheos System is developed by CVRx Inc. of Minneapolis. The device controls blood pressure much like a pacemaker regulates heart rhythm. The device activates specific receptors on the arteries, known as carotid baroreceptors which are key regulators of blood flow in the body. These activated receptors then send signals that are interpreted by the brain as a rise in blood pressure. The procedure also relaxes the blood vessels and reduces the heart rate.
The device was tested on large number of patients and the results were positive. John Bisognano, a lead Study Investigator from the University of Rochester Medical Center said that these results are not common and ordinary. The device is required to undergo more focused trails before sending it for approval from the .S. Food and Drug Administration.
(source:http://topnews.net.nz)
============================================================
Submitted by Neeraj Shahane on Wed, 04/06/2011 - 10:51
Scientists have developed a device called Rheos System, to control the blood pressure of patients with resistant hypertension. In clinical trials, the device has helped lowering the blood pressure of the patients by 33%. The trials were conducted on 265 patients with resistant hypertension treated at 40 medical centers in the United States and two in Europe.The Rheos System is developed by CVRx Inc. of Minneapolis. The device controls blood pressure much like a pacemaker regulates heart rhythm. The device activates specific receptors on the arteries, known as carotid baroreceptors which are key regulators of blood flow in the body. These activated receptors then send signals that are interpreted by the brain as a rise in blood pressure. The procedure also relaxes the blood vessels and reduces the heart rate.
The device was tested on large number of patients and the results were positive. John Bisognano, a lead Study Investigator from the University of Rochester Medical Center said that these results are not common and ordinary. The device is required to undergo more focused trails before sending it for approval from the .S. Food and Drug Administration.
(source:http://topnews.net.nz)
============================================================
No comments:
Post a Comment